- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, December 8, 2023
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article in Express Healthcare Management referenced a study published in the November 2023 issue of The American Journal of Managed Care® (AJMC®). The study, “All-Payer Value-Based Contracting in Organizations With Medicare ACOs,” found that approximately 75% of providers had reported value-based contracts with commercial and Medicare Advantage plans alongside their Medicare accountable care organization contract.
A study entitled “Characteristics of Self-Triaged Emergency Department Visits by Adults With Cancer,” published in the September 2023 issue of AJMC, was referenced in an article from Healio. The study found that self-assessment of clinical severity of acute needs could be difficult in adults with cancer but those adults would rarely use a telephone triage line.
An article from Forbes referenced a study published in the March 2010 issue of AJMC. The study, “Economics of Influenza Vaccine Administration Timing for Children,” reported that vaccinating children for influenza in September or October could have an economic benefit to both society and third-party payers, with this economic benefit lasting through December.
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
On the Path to Greater Precision in Treating Multiple Myeloma
August 18th 2025Past efforts to collect data and to understand the relationship between minimal residual disease and outcomes will allow help researchers in multiple myeloma develop a new generation of targeted therapies, decide when treatment can be stopped, and possibly screen populations for the disease.
Read More
What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD
August 5th 2025Explore innovative strategies to enhance heart failure treatment through guideline-directed medical therapy, remote monitoring, and artificial intelligence–driven solutions for better patient outcomes.
Listen
